The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Current industrial practices of assessing permeability and P-glycoprotein interaction
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304
High throughput artificial membrane permeability assay for blood–brain barrier
Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00012-6 · Cited by 1,195
Role of P-Glycoprotein in Pharmacokinetics: Clinical Implications
Lin, J. H., & Yamazaki, M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00003 · Cited by 998
Upper Gastrointestinal (GI) pH in Young, Healthy Men and Women
Dressman, J. B., Berardi, R. R., Dermentzoglou, L. C., Russell, T. L., Schmaltz, S. P., Barnett, J. L., & Jarvenpaa, K. M. (1990) · Pharmaceutical Research · doi:10.1023/a:1015827908309 · Cited by 775
Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery
Polli, J. W., Wring, S. A., Humphreys, J. E., Huang, L., Morgan, J. B., Webster, L. O., & Serabjit-Singh, C. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29270-3 · Cited by 662
Physicochemical Profiling (Solubility, Permeability and Charge State)
Avdeef, A. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013395100 · Cited by 587
Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
Rege, B. D., Kao, J. P. Y., & Polli, J. E. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00055-6 · Cited by 509
Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein
Kirn, R. B., Wandel, C., Leake, B., Cvetkovic, M., Fromm, M. F., Dempsey, P. J., Roden, M. M., Belas, F., Chaudhary, A. K., Roden, D. M., et al. (1999) · Pharmaceutical Research · doi:10.1023/a:1018877803319 · Cited by 454
Sun, D., Lennernas, H., Welage, L. S., Barnett, J. L., Landowski, C. P., Foster, D., Fleisher, D., Lee, K.-D., & Amidon, G. L. (2002) · Pharmaceutical Research · doi:10.1023/a:1020483911355 · Cited by 447
Upper Gastrointestinal pH in Seventy-Nine Healthy, Elderly, North American Men and Women
Russell, T. L., Berardi, R. R., Barnett, J. L., Dermentzoglou, L. C., Jarvenpaa, K. M., Schmaltz, S. P., & Dressman, J. B. (1993) · Pharmaceutical Research · doi:10.1023/a:1018970323716 · Cited by 367
Flavonoids Are Inhibitors of Breast Cancer Resistance Protein (ABCG2)-Mediated Transport
Zhang, S., Yang, X., & Morris, M. E. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1208 · Cited by 359
High throughput physicochemical profiling for drug discovery
Kerns, E. H. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1134 · Cited by 343
Current methodologies used for evaluation of intestinal permeability and absorption
Balimane, P. V., Chong, S., & Morrison, R. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00113-1 · Cited by 319
Self-citationDrug–drug interaction mediated by inhibition and induction of P-glycoprotein
Lin, J. H. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00171-0 · Cited by 309
Cell culture-based models for intestinal permeability: A critique
Balimane, P. V., & Chong, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03354-9 · Cited by 278
Self-citationKerns, E. H., Di, L., Petusky, S., Farris, M., Ley, R., & Jupp, P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20075 · Cited by 275
Yamazaki, M., Neway, W. E., Ohe, T., Chen, I.-W., Rowe, J. F., Hochman, J. H., Chiba, M., & Lin, J. H. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38809-3 · Cited by 238
Maliepaard, M., van Gastelen, M. A., Tohgo, A., Hausheer, F. H., van Waardenburg, R. C. A. M., de Jong, L. A., Pluim, D., Beijnen, J. H., & Schellens, J. H. M. (2001) · PubMed · Cited by 231
Cell cultures as models for drug absorption across the intestinal mucosa.
Artursson, P. (1991) · PubMed · Cited by 230
Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease Inhibitor
Polli, J. W., Jarrett, J. L., Studenberg, S. D., Humphreys, J. E., Dennis, S. W., Brouwer, K. R., & Woolley, J. L. (1999) · Pharmaceutical Research · doi:10.1023/a:1018941328702 · Cited by 218
Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.
Volk, E. L., & Schneider, E. (2003) · PubMed · Cited by 215
Effect of Common Excipients on Caco-2 Transport of Low-Permeability Drugs
Rege, B. D., Yu, L. X., Hussain, A. S., & Polli, J. E. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1127 · Cited by 206
Simpson, K., & Jarvis, B. (2000) · Drugs · doi:10.2165/00003495-200059020-00020 · Cited by 197
Comparative Studies on in Vitro Methods for Evaluating in Vivo Function of MDR1 P-Glycoprotein
Adachi, Y., Suzuki, H., & Sugiyama, Y. (2001) · Pharmaceutical Research · doi:10.1023/a:1013358126640 · Cited by 195
Assessing the Absorption of New Pharmaceuticals
Hidalgo, I. J. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013395010 · Cited by 190
In vitro systems for studying intestinal drug absorption
Hillgren, K. M., Kato, A., & Borchardt, R. T. (1995) · Medicinal Research Reviews · doi:10.1002/med.2610150202 · Cited by 182
Dantzig, A. H., Shepard, R. L., Law, K. L., Tabas, L., Pratt, S., Gillespie, J. S., Binkley, S. N., Kuhfeld, M. T., Starling, J. J., & Wrighton, S. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34974-2 · Cited by 179
Chen, Z.-S., Kawabe, T., Ono, M., Aoki, S., Sumizawa, T., Furukawa, T., Uchiumi, T., Wada, M., Kuwano, M., & Akiyama, S.-I. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.6.1219 · Cited by 178
Flux Measurements across Caco-2 Monolayers May Predict Transport in Human Large Intestinal Tissue
Rubas, W., Cromwell, M. E. M., Shahrokh, Z., Villagran, J., Nguyen, T.-N., Wellton, M., Nguyen, T.-H., & Mrsny, R. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950267+ · Cited by 160
Cell cultures as tools in biopharmacy
Braun, A., Hämmerle, S. P., Suda, K., Rothen‐Rutishauser, B., Günthert, M., Krämer, S. D., & Wunderli‐Allenspach, H. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00164-0 · Cited by 153
PAMPA—A drug absorption in vitro model
Avdeef, A., & Tsinman, O. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.008 · Cited by 152
Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2
Krishna, G. A., Chen, K.-J., Lin, C.-C., & Nomeir, A. A. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00698-6 · Cited by 147
Effects of Some Non-ionic Surfactants on Transepithelial Permeability in Caco-2 Cells
Dimitrijević, D., Shaw, A. J., & Florence, A. T. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001773805 · Cited by 137
Ingels, F., & Augustijns, P. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10408 · Cited by 118
Chong, S., Dando, S. A., Soucek, K. M., & Morrison, R. A. (1996) · Pharmaceutical Research · doi:10.1023/a:1016045820933 · Cited by 113
Self-citationWalter, E., & Kissel, T. (1995) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(95)00010-b · Cited by 102
PAMPA—a drug absorption in vitro model
Ruell, J. A., Tsinman, K., & Avdeef, A. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.08.006 · Cited by 98
Woehlecke, H., Pohl, A., Alder‐Baerens, N., Lage, H., & Herrmann, A. (2003) · Biochemical Journal · doi:10.1042/bj20030886 · Cited by 94
Rapid Assessment of P-Glycoprotein Inhibition and Induction in Vitro
Perloff, M. D., Störmer, E., Moltke, L. L., & Greenblatt, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1025092829696 · Cited by 85
Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers
Saha, P., & Kou, J. H. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00089-9 · Cited by 82
Ano, R., Kimura, Y., Shima, M., Matsuno, R., Ueno, T., & Akamatsu, M. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.10.002 · Cited by 73
Behrens, I., Kamm, W., Dantzig, A. H., & Kissel, T. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20062 · Cited by 65
Ungell, A.-L. B. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.11.003 · Cited by 64
Secretory Transport of Ranitidine and Famotidine across Caco-2 Cell Monolayers
Lee, K., Ng, C. M., Brouwer, K. L. R., & Thakker, D. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038521 · Cited by 44
Cited by
Why 90% of clinical drug development fails and how to improve it?
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.002 · Cited by 1,763
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Klaassen, C. D., & Aleksunes, L. M. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002014 · Cited by 807
The blood-brain barrier: an engineering perspective
Wong, A. D., Ye, M., Levy, A. F., Rothstein, J. D., Bergles, D. E., & Searson, P. C. (2013) · Frontiers in Neuroengineering · doi:10.3389/fneng.2013.00007 · Cited by 662
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
Metadata
- Authors
- Balimane, P. V., Han, Y.-H., & Chong, S.
- Venue
- The AAPS Journal
- Published
- 2006-03
- Volume
- 8
- Issue
- 1
- Pages
- E1-E13
- ISSN
- 1550-7416 (ISSN-L)
- OpenAlex
- W2083206079
- Cited by
- 258
- References
- 47
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.